全文获取类型
收费全文 | 4863063篇 |
免费 | 381244篇 |
国内免费 | 15570篇 |
专业分类
耳鼻咽喉 | 69703篇 |
儿科学 | 154622篇 |
妇产科学 | 132118篇 |
基础医学 | 727000篇 |
口腔科学 | 137702篇 |
临床医学 | 441730篇 |
内科学 | 880847篇 |
皮肤病学 | 119606篇 |
神经病学 | 399168篇 |
特种医学 | 191745篇 |
外国民族医学 | 903篇 |
外科学 | 747905篇 |
综合类 | 138406篇 |
现状与发展 | 24篇 |
一般理论 | 2781篇 |
预防医学 | 396225篇 |
眼科学 | 116348篇 |
药学 | 348578篇 |
22篇 | |
中国医学 | 12893篇 |
肿瘤学 | 241551篇 |
出版年
2021年 | 50810篇 |
2019年 | 59336篇 |
2018年 | 75777篇 |
2017年 | 57801篇 |
2016年 | 64233篇 |
2015年 | 76649篇 |
2014年 | 111427篇 |
2013年 | 177208篇 |
2012年 | 138820篇 |
2011年 | 146905篇 |
2010年 | 131002篇 |
2009年 | 130944篇 |
2008年 | 132954篇 |
2007年 | 143673篇 |
2006年 | 150781篇 |
2005年 | 145912篇 |
2004年 | 145737篇 |
2003年 | 135532篇 |
2002年 | 124663篇 |
2001年 | 184877篇 |
2000年 | 180641篇 |
1999年 | 162296篇 |
1998年 | 68377篇 |
1997年 | 63300篇 |
1996年 | 61185篇 |
1995年 | 61717篇 |
1994年 | 56001篇 |
1993年 | 51914篇 |
1992年 | 120529篇 |
1991年 | 116993篇 |
1990年 | 113068篇 |
1989年 | 110315篇 |
1988年 | 102055篇 |
1987年 | 100299篇 |
1986年 | 95050篇 |
1985年 | 93042篇 |
1984年 | 75485篇 |
1983年 | 66554篇 |
1982年 | 50472篇 |
1981年 | 46710篇 |
1980年 | 43971篇 |
1979年 | 67351篇 |
1978年 | 53221篇 |
1977年 | 46612篇 |
1976年 | 43240篇 |
1975年 | 45119篇 |
1974年 | 50815篇 |
1973年 | 48736篇 |
1972年 | 46177篇 |
1971年 | 43003篇 |
排序方式: 共有10000条查询结果,搜索用时 23 毫秒
1.
Kari Hemminki Kristina Sundquist Jan Sundquist Asta Försti Vaclav Liska Akseli Hemminki Xinjun Li 《International journal of cancer. Journal international du cancer》2023,152(6):1107-1114
Many environmental risk factors for hepatobiliary cancers are known but whether they are associated with specific cancer types is unclear. We present here a novel approach of assessing standardized incidence ratios (SIRs) of previously diagnosed comorbidities for hepatocellular carcinoma (HCC), gallbladder cancer (GBC), cholangiocarcinoma (CCA) and ampullary cancer. The 13 comorbidities included alcohol and nonalcohol related liver disease, chronic obstructive pulmonary disease, gallstone disease, viral and other kinds of hepatitis, infection of bile ducts, hepatic and other autoimmune diseases, obesity and diabetes. Patients were identified from the Swedish Inpatient Register from 1987 to 2018, and their cancers were followed from 1997 onwards. SIRs for HCC were 80 to 100 in men and women diagnosed with hepatitis C virus and they were also >10 in patients diagnosed with hepatitis B virus, other kind of hepatitis, hepatic autoimmune disease and nonalcohol related liver disease. Many of these risks, as well as alcohol related liver disease, were either specific to HCC or were shared with intrahepatic CCA. For GBC, CCA and ampullary cancer infection of bile ducts was the main risk factor. Gallstone disease, nonhepatic autoimmune diseases and diabetes were associated with all hepatobiliary cancers. The limitations of the study include inability to cover some rare risk factors and limited follow-up time. Many of the considered comorbidities are characterized by chronic inflammation and/or overt immune disturbance in autoimmune diseases. The results suggest that local chronic inflammation and a related immune disturbance is the carcinogenic trigger for all these cancers. 相似文献
2.
3.
4.
Espersen Caroline Modin Daniel Hoffmann Søren Hagemann Christoffer A. Hagemann Rikke A. Olsen Flemming J. Fritz-Hansen Thomas Platz Elke Møgelvang Rasmus Biering-Sørensen Tor 《The international journal of cardiovascular imaging》2022,38(1):131-140
The International Journal of Cardiovascular Imaging - Global longitudinal strain (GLS) has proven to be a powerful prognostic marker in various patient populations, but the prognostic value of... 相似文献
5.
Marco N. Iannone Stefano Stucchi Elia A. Turolla Chiara Beretta Samuele Ciceri Clizia Chinello Lisa Pagani Sergio Todde Patrizia Ferraboschi 《Journal of labelled compounds & radiopharmaceuticals》2022,65(3):48-62
In the last decade, the development of new radiopharmaceuticals for the imaging and therapy of prostate cancer has been a highly active and important area of research, especially focusing on the prostate-specific membrane antigen (PSMA), an antigen which is upregulated in prostate, as well as in other tumor cells. A large variety of PSMA ligands have been radiolabeled, to date. Among the various derivatives, PSMA-617 resulted to be one of the most interesting in terms of interaction with the antigen and clinical properties, and its lutetium-177 labeled version has recently been approved by regulatory agencies for therapeutic purposes. For this reasons, the radiolabeling with fluorine-18 of a PSMA-617 derivative might be of interest. Beside other methodologies to radiolabel macromolecules with fluorine-18, the “click-chemistry” approach resulted to be very useful, and the copper-catalyzed azide-alkyne cycloaddition (CuAAC) is considered one of most efficient and reliable. This paper proposes the synthesis of a suitable precursor for the radiolabeling with fluorine-18 of a new PSMA-617 derivative. The whole radiosynthetic procedure has been fully automated, and the final product, which proved to be stable in plasma, has been obtained with radiochemical yield and purity suitable for subsequent preclinical studies. 相似文献
6.
Härter Martin Koch-Gromus Uwe 《Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz》2022,65(3):267-269
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz - 相似文献
7.
8.
9.
Alicia C. McDonald PhD MPH Jeremy Gernand PhD Nathaniel R. Geyer DrPH Hongke Wu MD MPH Yanxu Yang MPH Ming Wang PhD 《Cancer》2022,128(9):1832-1839